A Growing Specialty Pharmaceutical Company
On May 7, 2018, Impax Laboratories, Inc. combined with Amneal Pharmaceuticals, Inc. (NYSE: AMRX). Today, we are working to integrate our business into the new Amneal and are excited about our future as one company.
About Amneal + Impax
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) is an integrated specialty pharmaceutical company powered by a robust U.S. generics business and a growing branded business. Following our recent combination with Amneal Pharmaceuticals, Inc., we are building one of the most dynamic pharmaceutical companies in our rapidly changing industry.
While staying true to our reputation for quality, service and value, we are reinventing our processes, our playbook and our creative partnerships. We are focused on delivering outcomes that meet important medical needs, make quality medicines more accessible and more affordable, and provide solutions for tomorrow’s health challenges.